Expansion Trial for Axitinib In Head And Neck Cancer

Clinical trial NCT02762513 · COMPLETED

Trial details

NCT number: NCT02762513
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2016-08-30
Primary completion: 2020-04-09
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.